retatrutide study results phase 2 This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #Endocrinology Perceived benefits of treatment for – retatrutide clinical trials efficacy safety

Leptin Leptin is an adipocyte-derived hormone that reflects energy storage (143)

Novo Nordisk has published phase 3 data showing that a dual therapy comprising cagrilintide and semaglutide (the GLP-1 agonist in Wegovy), coupled with lifestyle interventions, achieved an average of 13.7% weight loss in patients with type 2 diabetes, who are also overweight or obese, over a period of 68 weeks 8

2014;8(262275):e9

Not sold at your storeShipping unavailable Limited stock at your store Buy in store onlyShipping unavailable Out of stock at your storeShipping unavailable Not sold at your storeShipping unavailable Not sold at your storeShipping unavailable Not sold at your storeShipping unavailable Page navigationPage 1 of1Page 1 of 1 Online and store prices may vary * The total item count is approximate

Review full pharmacy documentation and consult your provider

Dont wait for metabolic syndrome or age-related decline to dictate your health future